Neurophysiology of Prophylactic Treatment in Migraine

CompletedOBSERVATIONAL
Enrollment

44

Participants

Timeline

Start Date

January 29, 2019

Primary Completion Date

May 2, 2021

Study Completion Date

May 2, 2021

Conditions
Migraine
Interventions
DRUG

antibodies against calcitonin-gene related peptide or its receptor

the study is observational and does not interfere with clinical routine. In lin with this notion, the intervention is chosen by the treating physician in a shared decision making process involving the patient

Trial Locations (1)

17475

Department of Neurology, Greifswald

All Listed Sponsors
lead

University Medicine Greifswald

OTHER

NCT04019496 - Neurophysiology of Prophylactic Treatment in Migraine | Biotech Hunter | Biotech Hunter